|
Purpose of the guideline：
|
1、Standardizing Clinical Medication: Provide unified medication standards to help clinicians correctly select and use parenteral direct thrombin inhibitors, improving treatment efficacy and safety.
2、Enhancing Medication Safety: Reduce medication errors through the establishment of guidelines, decrease drug-related adverse reactions and complications, and ensure patient medication safety.
3、Optimizing Treatment Regimens: Optimize treatment regimens for parenteral direct thrombin inhibitors based on the latest research and clinical evidence, improving patient treatment outcomes.
4、Providing Education and Training: Offer relevant training and educational resources for healthcare professionals to enhance their understanding and ability to use parenteral direct thrombin inhibitors.
5、Promoting Clinical Research: Clarify research directions and priorities through guideline development, driving clinical research and innovation in the field of parenteral direct thrombin inhibitors.
6、Unifying Treatment Standards: Establish consistent treatment standards across different medical institutions, reducing regional and institutional disparities in medication use, ensuring all patients receive consistent treatment. |
